First Time Loading...
R

Redx Pharma PLC
LSE:REDX

Watchlist Manager
Redx Pharma PLC
LSE:REDX
Watchlist
Price: 15 GBX 31.58% Market Closed
Updated: May 7, 2024
REDX
/
Cash Flow Statement
/
Cash from Financing Activities

Redx Pharma PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redx Pharma PLC
Cash from Financing Activities Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
R
Redx Pharma PLC
LSE:REDX
Cash from Financing Activities
-£816k
CAGR 3-Years
N/A
CAGR 5-Years
-76%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash from Financing Activities
-£6.4B
CAGR 3-Years
15%
CAGR 5-Years
-21%
CAGR 10-Years
1%
AstraZeneca PLC
LSE:AZN
Cash from Financing Activities
-$2.5B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
2%
Indivior PLC
LSE:INDV
Cash from Financing Activities
-$62m
CAGR 3-Years
-78%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash from Financing Activities
-$337m
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash from Financing Activities
£316.5m
CAGR 3-Years
39%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Redx Pharma PLC's Cash from Financing Activities?
Cash from Financing Activities
-816k GBP

Based on the financial report for Sep 30, 2023, Redx Pharma PLC's Cash from Financing Activities amounts to -816k GBP.

What is Redx Pharma PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-76%

ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.